Submitted by Anonymous (not verified) on 21 January 2026 - 15:20
Human medicines European public assessment report (EPAR): Abasaglar (previously Abasria), insulin glargine, Date of authorisation: 09/09/2014, Revision: 13, Status: Authorised
Source: